+919405117673
Afatinib 30mg Tablets – Global Supplier & Exporter from India | Fast Delivery to USA, UK, UAE & More
Looking for a reliable global supplier of Afatinib 30mg Tablets? Cordium Pharmaceuticals Pvt Ltd is a trusted exporter from India, delivering high-quality oncology medicines worldwide with fast and secure shipping.

πŸ’Š About Afatinib 30mg Tablets

Afatinib is a targeted therapy medication used in the treatment of certain types of non-small cell lung cancer (NSCLC). It works by blocking specific proteins (EGFR) that help cancer cells grow and spread, thereby slowing disease progression.

βš•οΈ Uses of Afatinib 30mg
Treatment of metastatic non-small cell lung cancer (NSCLC)
EGFR mutation-positive lung cancer therapy
Used in patients who have not responded to other treatments
πŸ“ Dosage & Administration
Typically prescribed as 30mg once daily, or as directed by a healthcare professional
Should be taken on an empty stomach (at least 1 hour before or 2 hours after meals)
Dosage may vary based on patient condition and response to treatment
Always follow your doctor’s prescription strictly
⚠️ Possible Side Effects

Like all medications, Afatinib may cause side effects, including:

Diarrhea
Skin rash or acne
Mouth sores
Nail infections
Decreased appetite
Fatigue

Serious side effects (seek immediate medical help):

Severe lung problems
Liver issues
Severe skin reactions
🌍 Global Export & Fast Delivery

Cordium Pharmaceuticals Pvt Ltd ensures safe, reliable, and fast delivery of Afatinib 30mg Tablets to:

United States
Germany
United Kingdom
Netherlands
South Africa
United Arab Emirates
Brazil

We maintain strict quality standards and compliance for international pharmaceutical exports.

πŸ“¦ Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global pharmaceutical exporter
Competitive pricing
Authentic & quality-assured medicines
Fast international shipping
Dedicated customer support
πŸ“ž Contact Us Today

πŸ“± WhatsApp: +91-9405117673
πŸ“§ Email: info@cordiumpharma.com

Get in touch for bulk orders, pricing, and export inquiries.
Apr 19th, 2026 3:57 PM

Keywords